Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Spinal Cord Injuries
Interventions
DRUG

Minocycline

Minocycline IV BID x 7 days (first 10 patients 200 mg/dose, subsequent patients adjusted based on pharmacodynamic profiling to 800 mg loading dose, tapered 100 mg each dose to 400 mg then maintain at 400mg until day 7)

DRUG

placebo

Normal saline 250cc via central line similar to minocycline arm administration protocol

PROCEDURE

SCPP augmentation

maintenance of spinal cord perfusion pressure at 75 mmHg with fluids and inotrope protocol

PROCEDURE

SCPP control

maintenance of Mean arterial pressure of \>65 mmHg with fluids and inotropes protocol without spinal cord perfusion pressure as target or guiding therapy

Trial Locations (1)

T2N 2T9

Foothills Medical Centre, Calgary

All Listed Sponsors
collaborator

Paralyzed Veterans of America

OTHER

collaborator

American Association of Neurological Surgeons

OTHER

collaborator

Hotchkiss Brain Institute, University of Calgary

OTHER

lead

University of Calgary

OTHER

NCT00559494 - Minocycline and Perfusion Pressure Augmentation in Acute Spinal Cord Injury | Biotech Hunter | Biotech Hunter